Grand challenges issued

Gates initiative joins growing number of urgent research to-do lists

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Ten months after Microsoft founder Bill Gates announced his "Grand Challenges in Global Health" research initiative in Davos, Switzerland, a hand-picked panel of international scientists has drafted a list of 14 challenges, whose solutions could lead to important healthcare advances for the developing world. The list appears in today's issue of the journal Science.

The 14 challenges include controlling infectious disease through new and improved vaccines and better management and eradication of the insects that transmit agents of disease. Others call for improved nutrition and better disease measurement in both individuals and populations. Each challenge will receive grants of up to $20 million over 5 years or less. The Bill and Melinda Gates Foundation is funding this $200 million project, which is administered by the Foundation for the National Institutes of Health.

A description of deliberations that led to selection of the 14 global health challenges and an outline of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Diane Martindale

    This person does not yet have a bio.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development